Taysha Gene Therapies, Inc. (TSHA) Revenue 2022–2025
Taysha Gene Therapies, Inc. (TSHA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$9.8MFY2025 · since FY2022: $2.5M → $9.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.8M | +17.3% |
| FY2024 | $8.3M | -46.1% |
| FY2023 | $15.5M | +517.5% |
| FY2022 | $2.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice